AuKing Mining Limited (ASX:AKN) has issued 5,799,000 fully paid ordinary shares following the exercise of an equivalent number of December 2026 $0.006 options (AKNO), according to a Section 708A notice filed on 6 November 2026.
Key Points
- 5,799,000 fully paid ordinary shares issued on 6 November 2026 under Section 708A(5)(e) of the Corporations Act
- Shares issued in relation to the exercise of 5,799,000 December 2026 $0.006 options (AKNO)
- Shares issued without disclosure to investors under Part 6D.2 of the Corporations Act 2001
- The company disclosed it is in regular receipt of assay results from initial drilling at Tundulu, with several thousand samples still to be processed and assayed over the next 2–3 months
Section 708A Securities Issue Details
AuKing Mining filed a Section 708A(5)(e) notice with the ASX on 6 November 2026, disclosing the issue of 5,799,000 fully paid ordinary shares. The shares were issued in connection with the exercise of 5,799,000 December 2026 $0.006 options carrying the ticker AKNO. An Appendix 2A form detailing the new securities issue was also lodged with the ASX on the same date. The ordinary shares form part of a class of securities quoted on the Australian Securities Exchange and were issued without disclosure to investors under Part 6D.2 of the Corporations Act 2001.
Corporations Act Compliance Statements
As a disclosing entity, AuKing Mining confirmed it has, as at the date of the notice, complied with the provisions of Chapter 2M of the Corporations Act 2001 as they apply to the company, as well as Sections 674 and 674A of the Corporations Act 2001. The company stated that, save for the matter relating to assay results from Tundulu, there is no excluded information of the type referred to in Sections 708A(7) and (8) of the Corporations Act 2001 as at the date of the filing.
Tundulu Drilling Assay Results Noted as Confidential Pending Reporting
AuKing Mining disclosed that the company is in regular receipt of assay results from initial drilling at Tundulu, with several thousand samples still to be processed and assayed. The company stated this situation will likely continue for the next 2–3 months. Upon receipt of assay results from the Intertek laboratory, AuKing, in conjunction with the Competent Person, will collate and interpret all data and prepare reports in accordance with its continuous disclosure obligations. The company stated every effort is being made to report the information as soon as possible, and that until reported, the results should be regarded as confidential and incomplete.



Please wait processing your request...